Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X4JN
|
|||
Former ID |
DIB014095
|
|||
Drug Name |
Pelubiprofen
|
|||
Synonyms |
Pelubi; Rubione; CS-670; DW-330; RS-2131
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Back pain [ICD-11: ME84.Z] | Approved | [1] | |
Company |
Sankyo Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H18O3
|
|||
Canonical SMILES |
CC(C1=CC=C(C=C1)C=C2CCCCC2=O)C(=O)O
|
|||
InChI |
1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+
|
|||
InChIKey |
AUZUGWXLBGZUPP-GXDHUFHOSA-N
|
|||
CAS Number |
CAS 69956-77-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin G/H synthase (COX) | Target Info | Modulator | [1], [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF- B inactivation. J Cell Biochem. 2011 Dec;112(12):3594-603. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.